Search company, investor...

Total Raised

$217.34M

Investors Count

13

Deal Terms

4

Funding, Valuation & Revenue

15 Fundings

ViewRay has raised $217.34M over 15 rounds.

ViewRay's latest funding round was a Bankrupt/Admin for on July 17, 2023.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/17/2023

Bankrupt/Admin

$99M

0

FY undefined

1

7/24/2015

Reverse Merger

$99M

0

FY undefined

2

6/30/2015

Debt - II

$50M

$99M

0

FY undefined

2

3/4/2015

Unattributed

$99M

$99M

0

FY undefined

10

1/8/2015

Series D - IV

$99M

$99M

0

FY undefined

10

Date

7/17/2023

7/24/2015

6/30/2015

3/4/2015

1/8/2015

Round

Bankrupt/Admin

Reverse Merger

Debt - II

Unattributed

Series D - IV

Amount

$50M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

2

2

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

ViewRay Deal Terms

4 Deal Terms

ViewRay's deal structure is available for 4 funding rounds, including their Unattributed from March 04, 2015.

Round

Unattributed

Series D

Series C - II

Series B

Funding Date

$99M

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Unattributed

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series D

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

ViewRay Investors

13 Investors

ViewRay has 13 investors. ViewRay Technologies invested in ViewRay's Reverse Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/24/2015

7/24/2015

1
Reverse Merger

Holding Company

United States

6/30/2015

6/30/2015

1
Debt - II

Debt & Specialty Finance

Texas

1/15/2008

1/8/2015

8
Series B, Series C (2010), Debt (2011), Series C - II (2012), Series D (2013), Series D - II (2013), Series D - III (2013), Series D - IV (2015)

Venture Capital

California

00/00/0000

00/00/0000

OrbiMed Advisors

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

F-Prime Capital

Subscribe to see more

Venture Capital

Massachusetts

First funding

7/24/2015

6/30/2015

1/15/2008

00/00/0000

00/00/0000

Last Funding

7/24/2015

6/30/2015

1/8/2015

00/00/0000

00/00/0000

Investor

OrbiMed Advisors

F-Prime Capital

Rounds

1
Reverse Merger
1
Debt - II
8
Series B, Series C (2010), Debt (2011), Series C - II (2012), Series D (2013), Series D - II (2013), Series D - III (2013), Series D - IV (2015)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Debt & Specialty Finance

Venture Capital

Venture Capital

Venture Capital

Location

United States

Texas

California

New York

Massachusetts

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare ViewRay to Competitors

C
Calpyso Medical

Calypso Medical provides technologies in the radiation oncology market

R
Radiation Shield Technologies

Radiation Shield Technologies specializes in the research, design, and production of personal protection systems within the safety and defense industry. The company offers products such as full body suits, blankets, and tents made from a patented, lightweight, non-toxic, and lead-free fabric called Demron, which is designed to protect individuals from ionizing and nuclear radiation. These products are aimed at providing safety for users in environments where radiological or nuclear hazards are present. It is based in Coral Gables, Florida.

Smart Animal Logo
Smart Animal

Smart Animal is a research company focused on personalized medicine within the immunotherapy and diagnostics sectors. They offer a platform-oriented device that modifies or enhances the body's immune response to target diseases, administered in outpatient settings. The company's technology is used for labeling antibodies for imaging and targeted drug delivery in cancer treatment and can be applied to autoimmune disorders and veterinary use. It was founded in 2006 and is based in Marlborough, Massachusetts.

CivaTech Oncology Logo
CivaTech Oncology

Civatech Oncology is a medical device company focused on the development of polymer-based devices that treat cancer using localized, low-dose-rate radiation. The company's fabrication methods allow for the encapsulation of radioactive materials into polymer structures. These polymer-based brachytherapy devices offer physicians treatment options for tumors with low-dose-rate brachytherapy. CivaTech Oncology was founded in 2006 and is based in Durham, North Carolina.

I
InnerOptic

InnerOptic Technology, Inc. specializes in augmented reality and image guidance systems for the medical sector. The company offers FDA-cleared 3D navigation tools designed to enhance the precision and safety of medical procedures. These products are primarily utilized in the healthcare industry to assist with interventions such as needle navigation and surgical procedures. It is based in Hillsborough, North Carolina.

HyperMed Imaging Logo
HyperMed Imaging

HyperMed Imaging is a company focused on medical hyperspectral imaging within the healthcare industry. The company's main offering is advanced portable imaging technology that assesses oxyhemoglobin, deoxyhemoglobin, and oxyhemoglobin saturation in superficial tissue, providing key information for various healthcare applications. The primary sector HyperMed Imaging serves is the healthcare industry, specifically in areas requiring quick and efficient determination of surface tissue oxygenation. It was founded in 1997 and is based in Memphis, Tennessee.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.